An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
BIMI International Medical Inc. (BIMI) announced the buyback of 7,066,913 warrants at $0.30 per share, totaling $2,120,073.80. The warrants will be cancelled upon receipt of the purchase price.
Positive
None.
Negative
None.
NEW YORK, NY, Nov. 28, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, "BIMI"), a healthcare products and services provider, today announced its entry into material definitive agreements with certain of its warrant holders, pursuant to which BIMI agreed to buy back an aggregate of 7,066,913 warrants to purchase shares of common stock of the Company from these warrant holders. BIMI agreed to pay $0.30 for each share of common stock underlying the warrant, or an aggregate purchase price of $2,120,073.80 to the warrant holders within three (3) business days (for certain sellers), or two (2) months (for certain other sellers), of the signing of the agreements. The warrants will be deemed cancelled upon the receipt by the sellers of the purchase price.
About BIMI International Medical Inc.
BIMI International Medical Inc. is a healthcare products and services provider, offering a broad range of healthcare products and related services in the U.S. and Asia. For more information, please visit www.usbimi.com.
Safe Harbor Statement
Certain matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties including, but not limited to, the Company’s ability to achieve profitable operations, its ability to continue to operate as a going concern, its ability to continue to meet NASDAQ continued listing requirements, the effects of the spread of COVID-19, the demand for the Company’s products and services in the People’s Republic of China, the continued positive results of the recently acquired Phenix Bio subsidiary, general economic conditions and other risk factors detailed in the Company’s annual report and other filings with the United States Securities and Exchange Commission.
IR Contact:
Investor Relations Department of BIMI International Medical Inc.
bimi international medical inc. (nasdaq: bimi) is an american multinational healthcare products and services provider, offering a broad range of healthcare products and related services. the company currently operates in four segments: wholesale pharmaceuticals, wholesale medical devices, medical services and retail pharmacy. the wholesale pharmaceuticals segment includes supplying prescription and otc medicines, traditional chinese medicines (“tcm”), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers. the wholesale medical devices segment distributes medical devices, including medical consumables to private clinics, hospitals, third party pharmacies and other medical device dealers. medical services include private comprehensive hospitals operating in china. the retail pharmacy segment sells prescription and otc medicines, tcm, healthcare supplies and sundry items to retail customers through its directly-owned pharmacies a
